SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-013522
Filing Date
2022-05-16
Accepted
2022-05-16 08:01:08
Documents
76
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1430343
2 ex31-1.htm EX-31.1 20043
3 ex31-2.htm EX-31.2 20371
4 ex32-1.htm EX-32.1 8656
  Complete submission text file 0001493152-22-013522.txt   6657908

Data Files

Seq Description Document Type Size
5 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT clsn-20220331.xsd EX-101.SCH 50082
6 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT clsn-20220331_cal.xml EX-101.CAL 66119
7 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT clsn-20220331_def.xml EX-101.DEF 211183
8 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT clsn-20220331_lab.xml EX-101.LAB 411694
9 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT clsn-20220331_pre.xml EX-101.PRE 319946
70 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1067514
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Celsion CORP (Filer) CIK: 0000749647 (see all company filings)

IRS No.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15911 | Film No.: 22925592
SIC: 2834 Pharmaceutical Preparations